Acute inhibition of glutathione biosynthesis alters endothelial function and blood pressure in rats

European Journal of Pharmacology

Volumn 454, Issue 2-3, 2002, Pages 217-223

  Ganafa, Agaba A ^a   Socci, Robin R ^a   Eatman, Danita ^a   Silvestrova, Natalia ^a   Abukhalaf, Imad K ^a   Bayorh, Mohamed A ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Endothelial function; Glutathione; Oxidative stress

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; ISOPROSTANE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROSTACYCLIN; SODIUM CHLORIDE; SUCCINIC ACID; SUPEROXIDE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; NON-PROGRAMMATIC; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

NON-PROGRAMMATIC;

ANIMALS; BLOOD PRESSURE; BUTHIONINE SULFOXIMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLUTATHIONE; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037111130     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02500-1     Document Type: Article

References (28)

1. Bayorh A.M., Socci R.R., Watts S., Wang M., Eatman D., Emmet N., Thierry-Palmer M. L-NAME, a nitric oxide synthase inhibitor, as a potential countermeasure to post-suspension hypotension in rats. Clin. Exp. Hypertens. 23(8):2001;611-622.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Cowley A.W. Jr., Mattson D.L., Lu S., Roman R.J. The renal medulla and hypertension. Hypertension. 25:1995;663-673.
4. Davidge S.T. Prostaglandin H synthase and vascular function. Circ. Res. 89(8):2001;650-660.
5. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18:2000;655-673.
6. Drew R., Miners O.J. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem. Pharmacol. 33(19):1984;2989-2994.
7. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-Butyl homocysteine Sulfoximine). J. Biol. Chem. 254:1979;7558-7560.
8. Griffith O.W., Meister A. Glutathione: interorgan translocation, turnover and metabolism. Proc. Natl. Acad. Sci. U. S. A. 76:1997;5606-5610.
9. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 411:1997;157-160.
10. Halliwell B., Gutteridge J.M. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. Free Radicals in Biology and Medicine. 2nd ed. 1989;87-187 Clarendon Press, Oxford, UK.
11. Jones D.P., Maellaro E., Jiang S., Slater A.F.G., Orrenius S. Effects of N-acetyl-L-cysteine on T cell apoptosis are not mediated by increased cellular glutathione. Immunol. Lett. 45:1995;205-209.
12. Katusic Z.S., Vanhoutte P.M. Superoxide anion is an endothelium-derived contracting factor. Am. J. Physiol. 257(1 Part 2):1989;H33-H37.
13. Kim M.O., Phyllis E.B. Oxidative stress in critical care: is antioxidant supplementation beneficial? J. Am. Diet. Assoc. 98:1998;1001-1008.
14. Maynard P.M., Graupper W.G., Botjje W.G. Effect of glutathione depletion on tissue and plasma prostacyclin and thromboxane in rats. Biochem. Pharmacol. 43:1992;1043-1051.
15. Meister A. Selective modification of glutathione metabolism. Science. 220:1984;472-477.
16. 2 in the aorta of the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 33:1999;605-610.
17. Peng X., Li Y. Induction of cellular glutathione-linked enzymes and catalase by the unique chemoprotective agent, 3H-1,2-dithiole-3-thione in rat cardiomyocytes affords protection against oxidative cell injury. Pharmacol. Res. 45(6):2002;491-495.
18. Quyyumi A.A., Dakak N., Andrews N.P., Husain S., Arora S., Gilligan D.M., Panza J.A., Cannon R.O. III Nitric oxide activity in the human coronary circulation. J. Clin. Invest. 95:1995;1747-1755.
19. Schiffrin E.L. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J. Cardiovasc. Pharmacol. 38(Suppl. 2):2001;S3-S6.
20. 2α. Hypertension. 33:1999;424-428.
21. Sharma R.C., Crawford D.W., Kramsch D.M., Sevanian A., Jiao Q. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and artherosclerotic arteries: role of oxygen free radicals. Arterioscler. Thromb. 12:1992;403-415.
22. Szekacs B., Nadasy G.L., Vajo Z., Juhasz I., Feher J., Monos E. Prostacyclin and thromboxane production of rat and cat arterial tissue is altered independently by several vasoactive substances. Prostaglandins. 52(3):1996;221-235.
23. Taylor A.A. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol. Metab. Clin. N. Am. 30(4):2001;983-997.
24. Tesfamariam B., Cohen R.A. Role of superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am. J. Physiol. 262:1992;H1915-H1919.
25. Uehera Y., Numabe A., Takada S. Possible role of prostacyclin synthase in altered prostacyclin generation in DOCA-salt hypertensive rats. Am. J. Hypertens. 4:1991;667-673.
26. Vaziri N.D., Wang X.U., Oveisi F., Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 36:2000;142-146.
27. Zhou X.J., Vaziri N.D., Wang X.Q., Silva F.G., Laszikv Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J. Pharmacol. Exp. Ther. 300(3):2002;762-767.
28. Zou A., Li N., Cowley A.W. Jr. Production and actions of superoxide in the renal medulla. Hypertension. 37(Part 2):2001;547-553.